Radius Health Inc.
Radius Health Inc. logo
RDUS

Radius Health Inc. (RDUS)

$10.50.19%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$10.425
Day's Range
$10.66
$4.97
52-Week Range
$23.0
1 month return48.17%
3 month return18.07%
1 year return37.79%
5 year return75.74%

Company Information

Radius Health Inc. is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine and other therapeutics. Radius' lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide transdermal system for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group; and the investigational drug RAD011, a synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases, initially targeting Prader-Willi syndrome.
OrganizationRadius Health Inc.
Employees310
CEOG. Kelly Martin
IndustryHealth Technology

Analyst Recommendation

based on 12 analysts ratings

Hold
0%
Buy
58%
Hold
41%
Sell

Based on 12 Wall street analysts offering stock ratings for Radius Health Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 7.7%

Current

$10.52

Target

$11.33

Recommendation Trend

Based on 12 analyst

Current1M Ago3M Ago
Buy
0
0
6
Hold
7
7
7
Sell
5
5
0
Consensus
HOLD
HOLD
HOLD

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
326.0M
Book Value
0.0
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.49
PEG Ratio
-0.16
Wall Street Target Price
9.67

Valuation

Trailing PE0.0
Forward PE18.05
Price/Sales (ttm)
1.42
Price/Book (mrq)
0.0
Enterprise Value
578.8M
Enterprise Value/Revenue
2.52
Enterprise Value/Ebitda
0.0

Technicals

Beta
0.93
50 Day MA
8.21
200 Day MA
11.74

Institutional Holdings

Bellevue Group AG

17.48%

Rubric Capital Management LP

14.62%

State Street Corporation

8.11%

Vanguard Group Inc

7.65%

BlackRock Inc

7.47%

Farallon Capital Management, L.L.C.

4.43%

Discover more

Frequently Asked Questions

What is Radius Health Inc. share price today?

Can Indians buy Radius Health Inc. shares?

How can I buy Radius Health Inc. shares from India?

Can Fractional shares of Radius Health Inc. be purchased?

What are the documents required to start investing in Radius Health Inc. stocks?

What are today’s High and Low prices of Radius Health Inc.?

What are today’s traded volumes of Radius Health Inc.?

What is today’s market capitalisation of Radius Health Inc.?

What is the 52 Week High and Low Range of Radius Health Inc.?

How much percentage Radius Health Inc. is down from its 52 Week High?

How much percentage Radius Health Inc. is up from its 52 Week low?

What are the historical returns of Radius Health Inc.?

Who is the Chief Executive Officer (CEO) of Radius Health Inc.?